Glenmark Will Pay $15.3M To End Humana's Price-Fixing Claims
The U.S. arm of Glenmark Pharmaceuticals Ltd. has agreed to settle generic-drug price-fixing claims brought by Humana Inc. in three lawsuits centralized in Pennsylvania-based multidistrict litigation, according to a filing with...To view the full article, register now.
Already a subscriber? Click here to view full article